Human herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients

scientific article

Human herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P6179Dimensions Publication ID1030628547
P356DOI10.1007/BF03165124
P698PubMed publication ID12430932

P2093author name stringDuncan A Clark
P2860cites workCD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virusQ24563446
In vitro activation of human herpesviruses 6 and 7 from latencyQ24632436
Determination and analysis of the complete nucleotide sequence of human herpesvirusQ24681462
Human herpesvirus-6 infection in children. A prospective study of complications and reactivationQ28245288
Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young childrenQ33330262
Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitroQ33331500
Human herpesvirus 6 infection after living related liver transplantationQ33333492
Human herpesvirus 7.Q33782445
Reactivation of human herpesvirus 6 by infection of human herpesvirus 7.Q33886225
Human herpesvirus-6 and -7 in transplantationQ34176585
Presence of human herpesvirus 6 variants A and B in saliva and peripheral blood mononuclear cells of healthy adultsQ36542278
CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B.Q36662337
Human herpesvirus 7 is a constitutive inhabitant of adult human salivaQ36697673
The indirect effects of cytomegalovirus infection on the outcome of organ transplantationQ38271609
The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolutionQ39027478
Human herpesvirus 6 latently infects early bone marrow progenitors in vivo.Q39549015
Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus.Q40116280
Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients.Q40613007
Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcomeQ40617928
Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virusQ40617934
Fever in liver transplant recipients: changing spectrum of etiologic agents.Q40642548
Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivoQ40720799
Genetic variations of human herpesvirus 7 by analysis of glycoproteins B and H, and R2-repeat regionsQ40756779
Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantationQ40837247
Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.Q41263267
Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6Q41674350
Comparison of antiviral compounds against human herpesvirus 6 and 7.Q42537404
Human beta-herpesvirus interactions in solid organ transplant recipientsQ43512377
Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity.Q43551491
"Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?Q43604508
Endonuclease analyses of DNA of human herpesvirus-6 isolated from blood before and after bone marrow transplantationQ43715620
Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients.Q43743487
Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipientsQ43843926
Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirusQ43962601
Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: random tests and prospective longitudinal studiesQ43975743
Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction.Q44071322
Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hostsQ44282119
CD46 is a cellular receptor for human herpesvirus 6.Q44613357
Latent human herpesvirus 6 infection of human monocytes/macrophagesQ44855928
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study GroupQ45095772
Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factorsQ45124793
Prevalence of blood-borne viral infections (cytomegalovirus, human herpesvirus-6, human herpesvirus-7, human herpesvirus-8, human T-cell lymphotropic virus-I/II, human retrovirus-5) among blood donors in LatviaQ45734360
Primary human herpes virus 6 infection transmitted from donor to recipient through bone marrow infusionQ45755455
Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovirQ45758947
Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group.Q45769083
Is human herpes virus 6 (HHV-6) infection associated with posttransfusion hepatitis?Q45861342
Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantationQ47980468
Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipientQ48123460
Persistence of human herpesvirus 7 in normal tissues detected by expression of a structural antigenQ48400605
Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation.Q52029727
Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction.Q53017289
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.Q53346269
Prevalence of antibody to human herpesvirus 7 by age.Q55066194
PROSPECTIVE STUDY OF HUMAN BETAHERPESVIRUSES AFTER RENAL TRANSPLANTATIONQ57181387
High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patientsQ58473705
Quantification of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCRQ58474004
Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipientsQ59699905
Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donorQ69351317
Age prevalence of antibody to human herpesvirus 6Q69917870
Identification of human herpesvirus-6 as a causal agent for exanthem subitumQ69917877
Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantationQ70461192
A prospective study of human herpesvirus type 6 detected by polymerase chain reaction after liver transplantationQ71023475
Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantationQ71128063
Longitudinal study of human herpesvirus 6 infection in organ transplant recipientsQ71575426
Lymphotropic herpesviruses in allogeneic bone marrow transplantationQ71735237
Human herpesvirus 7: another causal agent for roseola (exanthem subitum)Q72038183
Molecular epidemiological studies of human herpesvirus 6 in familiesQ72681195
HHV-6-related secondary graft failure following allogeneic bone marrow transplantationQ73165281
Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cellsQ73595172
Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipientsQ73670490
Human herpesvirus-6 and human herpesvirus-7 in the bone marrow from healthy subjectsQ73847384
Human herpesvirus-6 antigenemia after liver transplantationQ74052957
Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipientsQ74087779
Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?Q77292867
Prediction of human herpesvirus 6 infection after allogeneic bone marrow transplantationQ77328970
Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantationQ77418433
Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infectionQ77552310
Clinical impact of human herpesvirus 6 infection after liver transplantationQ77754761
Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestationsQ77759499
P921main subjectHuman herpesvirus 6Q6974
Human herpesvirus 7Q1169672
emerging pathogenQ108429945
P304page(s)246-252
P577publication date2002-08-01
P1433published inInternational Journal of HematologyQ6051416
P1476titleHuman herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients
P478volume76 Suppl 2

Reverse relations

cites work (P2860)
Q33271849Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome
Q40638537Differentiation and quantitation of human herpesviruses 6A, 6B and 7 by real-time PCR.
Q44564375Exanthema simulating measles without measles virus? Allergic reaction to a non-nucleoside reverse transcriptase inhibitor in an HIV infected boy treated with HAART
Q40244415HHV-6: clinical and laboratory investigations and correlations with encephalitis in liver transplant recipients
Q42281567Herpesvirus 6 glycoproteins B (gB), gH, gL, and gQ are necessary and sufficient for cell-to-cell fusion
Q40331363Human Herpesvirus 6A U14 Is Important for Virus Maturation
Q35764761Human Herpesvirus-6 U14 Induces Cell-Cycle Arrest in G2/M Phase by Associating with a Cellular Protein, EDD.
Q24635001Human herpesvirus 6 glycoprotein complex formation is required for folding and trafficking of the gH/gL/gQ1/gQ2 complex and its cellular receptor binding
Q36911805Identification of the human herpesvirus 6A gQ1 domain essential for its functional conformation
Q40047843Limbic Encephalitis Associated with Human Herpesvirus-7 (HHV-7) in an Immunocompetent Adult: The First Reported Case in Japan
Q93103575Multiplex qPCR facilitates identification of betaherpesviruses in patients with acute liver failure of unknown etiology
Q79270332Surveillance of active human herpesvirus 6 infection in chinese patients after hematopoietic stem cell transplantation with 3 different methods
Q41919167Viral Surveillance in Serum Samples From Patients With Acute Liver Failure By Metagenomic Next-Generation Sequencing

Search more.